These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 35212460)

  • 1. Recent Developments in Porous Silicon Nanovectors with Various Imaging Modalities in the Framework of Theranostics.
    Qian J; Wen H; Tamarov K; Xu W; Lehto VP
    ChemMedChem; 2022 May; 17(10):e202200004. PubMed ID: 35212460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives.
    Kumeria T; McInnes SJP; Maher S; Santos A
    Expert Opin Drug Deliv; 2017 Dec; 14(12):1407-1422. PubMed ID: 28398108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porous silicon nanoparticles for nanomedicine: preparation and biomedical applications.
    Santos HA; Mäkilä E; Airaksinen AJ; Bimbo LM; Hirvonen J
    Nanomedicine (Lond); 2014 Apr; 9(4):535-54. PubMed ID: 24787441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porous silicon-based sensing and delivery platforms for wound management applications.
    Duan W; Zhao J; Gao Y; Xu K; Huang S; Zeng L; Shen JW; Zheng Y; Wu J
    J Control Release; 2024 Jul; 371():530-554. PubMed ID: 38857787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy.
    Li W; Liu Z; Fontana F; Ding Y; Liu D; Hirvonen JT; Santos HA
    Adv Mater; 2018 Jun; 30(24):e1703740. PubMed ID: 29534311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porous silicon nanomaterials: recent advances in surface engineering for controlled drug-delivery applications.
    Zhang DX; Esser L; Vasani RB; Thissen H; Voelcker NH
    Nanomedicine (Lond); 2019 Dec; 14(24):3213-3230. PubMed ID: 31855121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional porous silicon for therapeutic drug delivery and imaging.
    Santos HA; Bimbo LM; Lehto VP; Airaksinen AJ; Salonen J; Hirvonen J
    Curr Drug Discov Technol; 2011 Sep; 8(3):228-49. PubMed ID: 21291407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in porous silicon technology for drug delivery.
    Barnes TJ; Jarvis KL; Prestidge CA
    Ther Deliv; 2013 Jul; 4(7):811-23. PubMed ID: 23883125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed inorganic porous nanovector with controlled release and MRI features for safe administration of doxorubicin.
    Näkki S; Wang JT; Wu J; Fan L; Rantanen J; Nissinen T; Kettunen MI; Backholm M; Ras RHA; Al-Jamal KT; Lehto VP; Xu W
    Int J Pharm; 2019 Jan; 554():327-336. PubMed ID: 30391665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and in vivo evaluation of red blood cell membrane coated porous silicon nanoparticles implanted with
    Jakobsson U; Mäkilä E; Rahikkala A; Imlimthan S; Lampuoti J; Ranjan S; Heino J; Jalkanen P; Köster U; Mizohata K; Santos HA; Salonen J; Airaksinen AJ; Sarparanta M; Helariutta K
    Nucl Med Biol; 2020; 84-85():102-110. PubMed ID: 32334356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graphene quantum dot-decorated luminescent porous silicon dressing for theranostics of diabetic wounds.
    Cui Y; Duan W; Jin Y; Wo F; Xi F; Wu J
    Acta Biomater; 2021 Sep; 131():544-554. PubMed ID: 34265475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-drug delivery by porous silicon nanoparticles for improved cellular uptake, sustained release, and combination therapy.
    Wang CF; Mäkilä EM; Kaasalainen MH; Hagström MV; Salonen JJ; Hirvonen JT; Santos HA
    Acta Biomater; 2015 Apr; 16():206-14. PubMed ID: 25637067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy.
    Kinnari PJ; Hyvönen ML; Mäkilä EM; Kaasalainen MH; Rivinoja A; Salonen JJ; Hirvonen JT; Laakkonen PM; Santos HA
    Biomaterials; 2013 Dec; 34(36):9134-41. PubMed ID: 24008034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-targeting peptide-functionalized porous silicon nanoparticles for cancer fluorescence imaging.
    Kanathasan JS; Palanisamy UD; Radhakrishnan AK; Chakravarthi S; Thong TB; Swamy V
    Nanomedicine (Lond); 2022 Sep; 17(21):1511-1528. PubMed ID: 36382634
    [No Abstract]   [Full Text] [Related]  

  • 15. Biodegradation model of porous silicon nanoparticles.
    Gongalsky MB; Sviridov AP; Bezsudnova YI; Osminkina LA
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110946. PubMed ID: 32172165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications.
    Jarvis KL; Barnes TJ; Prestidge CA
    Adv Colloid Interface Sci; 2012 Jul; 175():25-38. PubMed ID: 22521238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Analysis of Porous Silicon Nanoparticles Functionalization by
    Cheng R; Wang S; Moslova K; Mäkilä E; Salonen J; Li J; Hirvonen J; Xia B; Santos HA
    ACS Biomater Sci Eng; 2022 Oct; 8(10):4132-4139. PubMed ID: 34292713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics.
    Martinez JO; Chiappini C; Ziemys A; Faust AM; Kojic M; Liu X; Ferrari M; Tasciotti E
    Biomaterials; 2013 Nov; 34(33):8469-77. PubMed ID: 23911070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper-free azide-alkyne cycloaddition of targeting peptides to porous silicon nanoparticles for intracellular drug uptake.
    Wang CF; Mäkilä EM; Kaasalainen MH; Liu D; Sarparanta MP; Airaksinen AJ; Salonen JJ; Hirvonen JT; Santos HA
    Biomaterials; 2014 Jan; 35(4):1257-66. PubMed ID: 24211082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional porous silicon nanoparticles for cancer theranostics.
    Wang CF; Sarparanta MP; Mäkilä EM; Hyvönen ML; Laakkonen PM; Salonen JJ; Hirvonen JT; Airaksinen AJ; Santos HA
    Biomaterials; 2015 Apr; 48():108-18. PubMed ID: 25701036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.